New and Revised FDA Import Alerts for June 30
On June 30, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
- 99-05: Raw Agricultural Products for Pesticides (here)
- 98-06: New Tobacco Products Without Required Marketing Authorization (here)
- 80-04: Surgeon's and Patient Examination Gloves (here)
- 66-79: Drugs from Foreign Establishments Refusing FDA Inspection (here)
- 66-66: Active Pharmaceutical Ingredients (APIs) that appear to be Misbranded Under 502(f)(1) Because they do not meet the Requirements for the Labeling Exemptions in 21 CFR 201.122 (here)
- 54-14: Dietary Supplement Products from firms which have not met Dietary Supplement Good Manufacturing Practices (GMPs) (here).